469 related articles for article (PubMed ID: 19488082)
1. Management of agitation and aggression associated with Alzheimer disease.
Ballard CG; Gauthier S; Cummings JL; Brodaty H; Grossberg GT; Robert P; Lyketsos CG
Nat Rev Neurol; 2009 May; 5(5):245-55. PubMed ID: 19488082
[TBL] [Abstract][Full Text] [Related]
2. Management of agitation and aggression associated with Alzheimer's disease: controversies and possible solutions.
Ballard C; Corbett A; Chitramohan R; Aarsland D
Curr Opin Psychiatry; 2009 Nov; 22(6):532-40. PubMed ID: 19696673
[TBL] [Abstract][Full Text] [Related]
3. Agitation and aggression in people with Alzheimer's disease.
Ballard C; Corbett A
Curr Opin Psychiatry; 2013 May; 26(3):252-9. PubMed ID: 23528917
[TBL] [Abstract][Full Text] [Related]
4. Treatment of behavioral and psychological symptoms of Alzheimer's disease.
Corbett A; Smith J; Creese B; Ballard C
Curr Treat Options Neurol; 2012 Apr; 14(2):113-25. PubMed ID: 22328204
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological Management of Agitation and Aggression in Alzheimer's Disease: A Review of Current and Novel Treatments.
Liu CS; Ruthirakuhan M; Chau SA; Herrmann N; Carvalho AF; Lanctôt KL
Curr Alzheimer Res; 2016; 13(10):1134-44. PubMed ID: 27137221
[TBL] [Abstract][Full Text] [Related]
6. Management of neuropsychiatric symptoms in people with dementia.
Ballard C; Corbett A
CNS Drugs; 2010 Sep; 24(9):729-39. PubMed ID: 20806986
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological treatment of neuropsychiatric symptoms of dementia: a review of the evidence.
Franco KN; Messinger-Rapport B
J Am Med Dir Assoc; 2006 Mar; 7(3):201-2. PubMed ID: 16503315
[TBL] [Abstract][Full Text] [Related]
8. Progresses in treating agitation: a major clinical challenge in Alzheimer's disease.
Panza F; Solfrizzi V; Seripa D; Imbimbo BP; Santamato A; Lozupone M; Prete C; Greco A; Pilotto A; Logroscino G
Expert Opin Pharmacother; 2015; 16(17):2581-8. PubMed ID: 26389682
[TBL] [Abstract][Full Text] [Related]
9. [Pharmacological treatment of behavioral symptoms in dementia patients].
Gabryelewicz T
Przegl Lek; 2014; 71(4):215-20. PubMed ID: 25141581
[TBL] [Abstract][Full Text] [Related]
10. Atypical antipsychotics for the treatment of dementia-related behaviors: an update.
Daiello LA
Med Health R I; 2007 Jun; 90(6):191-4. PubMed ID: 17633594
[TBL] [Abstract][Full Text] [Related]
11. Agitation and aggression in Alzheimer's disease: an update on pharmacological and psychosocial approaches to care.
Gallagher D; Herrmann N
Neurodegener Dis Manag; 2015; 5(1):75-83. PubMed ID: 25711456
[TBL] [Abstract][Full Text] [Related]
12. The effectiveness of atypical antipsychotics for the treatment of aggression and psychosis in Alzheimer's disease.
Ballard C; Waite J
Cochrane Database Syst Rev; 2006 Jan; (1):CD003476. PubMed ID: 16437455
[TBL] [Abstract][Full Text] [Related]
13. Optimal nonpharmacological management of agitation in Alzheimer's disease: challenges and solutions.
Millán-Calenti JC; Lorenzo-López L; Alonso-Búa B; de Labra C; González-Abraldes I; Maseda A
Clin Interv Aging; 2016; 11():175-84. PubMed ID: 26955265
[TBL] [Abstract][Full Text] [Related]
14. Memantine for agitation/aggression and psychosis in moderately severe to severe Alzheimer's disease: a pooled analysis of 3 studies.
Wilcock GK; Ballard CG; Cooper JA; Loft H
J Clin Psychiatry; 2008 Mar; 69(3):341-8. PubMed ID: 18294023
[TBL] [Abstract][Full Text] [Related]
15. A double-blind randomized placebo-controlled withdrawal trial comparing memantine and antipsychotics for the long-term treatment of function and neuropsychiatric symptoms in people with Alzheimer's disease (MAIN-AD).
Ballard C; Thomas A; Gerry S; Yu LM; Aarsland D; Merritt C; Corbett A; Davison C; Sharma N; Khan Z; Creese B; Loughlin P; Bannister C; Burns A; Win SN; Walker Z;
J Am Med Dir Assoc; 2015 Apr; 16(4):316-22. PubMed ID: 25523285
[TBL] [Abstract][Full Text] [Related]
16. Management of behavioral and psychological symptoms in people with Alzheimer's disease: an international Delphi consensus.
Kales HC; Lyketsos CG; Miller EM; Ballard C
Int Psychogeriatr; 2019 Jan; 31(1):83-90. PubMed ID: 30068400
[TBL] [Abstract][Full Text] [Related]
17. Sequential drug treatment algorithm for agitation and aggression in Alzheimer's and mixed dementia.
Davies SJ; Burhan AM; Kim D; Gerretsen P; Graff-Guerrero A; Woo VL; Kumar S; Colman S; Pollock BG; Mulsant BH; Rajji TK
J Psychopharmacol; 2018 May; 32(5):509-523. PubMed ID: 29338602
[TBL] [Abstract][Full Text] [Related]
18. Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone.
De Deyn PP; Katz IR; Brodaty H; Lyons B; Greenspan A; Burns A
Clin Neurol Neurosurg; 2005 Oct; 107(6):497-508. PubMed ID: 15922506
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and Safety of ECT for Behavioral and Psychological Symptoms of Dementia (BPSD): A Retrospective Chart Review.
Hermida AP; Tang YL; Glass O; Janjua AU; McDonald WM
Am J Geriatr Psychiatry; 2020 Feb; 28(2):157-163. PubMed ID: 31668364
[TBL] [Abstract][Full Text] [Related]
20. Biological treatment of acute agitation or aggression with schizophrenia or bipolar disorder in the inpatient setting.
Correll CU; Yu X; Xiang Y; Kane JM; Masand P
Ann Clin Psychiatry; 2017 May; 29(2):92-107. PubMed ID: 28463343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
